tiprankstipranks
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market
GLAND
Gland Pharma Ltd.
RESEARCH TOOLSreports
Want to see IN:GLAND full AI Analyst Report?

Gland Pharma Ltd. (GLAND) Ratios

1 Followers

Gland Pharma Ltd. Ratios

IN:GLAND's free cash flow for Q2 2026 was ₹0.26. For the 2026 fiscal year, IN:GLAND's free cash flow was decreased by ₹ and operating cash flow was ₹0.20. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 4.68 4.68 4.33 4.04 9.46
Quick Ratio
 3.60 3.60 3.26 2.84 6.75
Cash Ratio
 2.09 2.09 1.63 0.26 2.62
Solvency Ratio
 0.67 0.67 0.51 0.57 1.13
Operating Cash Flow Ratio
 0.37 0.77 0.58 0.71 0.50
Short-Term Operating Cash Flow Coverage
 3.12 6.47 4.78 4.67 649.94
Net Current Asset Value
₹ 53.74B₹ 53.74B₹ 47.09B₹ 37.08B₹ 60.82B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.03 0.03 <0.01
Debt-to-Equity Ratio
 0.03 0.03 0.03 0.04 <0.01
Debt-to-Capital Ratio
 0.03 0.03 0.03 0.04 <0.01
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 <0.01
Financial Leverage Ratio
 1.21 1.21 1.23 1.22 1.10
Debt Service Coverage Ratio
 5.83 5.33 4.02 3.91 94.60
Interest Coverage Ratio
 36.24 36.24 72.45 69.56 155.35
Debt to Market Cap
 <0.01 <0.01 0.01 0.01 <0.01
Interest Debt Per Share
 19.24 19.23 20.50 24.18 0.72
Net Debt to EBITDA
 -1.77 -1.89 -1.82 0.01 -1.85
Profitability Margins
Gross Profit Margin
30.05%30.05%56.16%54.92%48.70%
EBIT Margin
20.66%18.75%15.53%17.15%24.40%
EBITDA Margin
27.08%25.34%21.92%22.89%28.44%
Operating Profit Margin
18.75%18.75%30.94%32.17%31.92%
Pretax Profit Margin
22.77%22.77%18.92%19.99%29.10%
Net Profit Margin
15.98%15.98%12.44%13.64%21.55%
Continuous Operations Profit Margin
15.98%15.98%12.44%13.64%21.55%
Net Income Per EBT
70.14%70.14%65.73%68.21%74.06%
EBT Per EBIT
121.45%121.45%61.15%62.14%91.16%
Return on Assets (ROA)
8.21%8.21%6.22%7.25%8.90%
Return on Equity (ROE)
10.75%9.92%7.63%8.85%9.81%
Return on Capital Employed (ROCE)
11.06%11.06%17.99%19.68%14.37%
Return on Invested Capital (ROIC)
7.63%7.63%11.58%13.09%10.64%
Return on Tangible Assets
8.48%8.48%6.43%7.49%8.91%
Earnings Yield
2.68%3.68%2.73%2.59%3.74%
Efficiency Ratios
Receivables Turnover
 3.40 3.40 3.70 3.44 3.50
Payables Turnover
 5.39 5.39 3.00 2.96 3.17
Inventory Turnover
 2.58 2.58 1.46 1.52 0.94
Fixed Asset Turnover
 1.45 1.45 1.42 1.46 2.09
Asset Turnover
 0.51 0.51 0.50 0.53 0.41
Working Capital Turnover Ratio
 1.14 1.15 1.19 1.09 0.63
Cash Conversion Cycle
 181.19 181.19 226.76 222.48 377.34
Days of Sales Outstanding
 107.35 107.35 98.55 106.20 104.32
Days of Inventory Outstanding
 141.50 141.50 249.83 239.58 388.30
Days of Payables Outstanding
 67.66 67.66 121.62 123.29 115.29
Operating Cycle
 248.86 248.86 348.38 345.78 492.63
Cash Flow Ratios
Operating Cash Flow Per Share
 36.02 74.73 55.52 60.51 22.10
Free Cash Flow Per Share
 24.24 44.94 32.18 36.84 8.55
CapEx Per Share
 11.77 29.79 23.34 23.67 13.55
Free Cash Flow to Operating Cash Flow
 0.67 0.60 0.58 0.61 0.39
Dividend Paid and CapEx Coverage Ratio
 1.21 1.56 1.28 2.56 1.63
Capital Expenditure Coverage Ratio
 3.06 2.51 2.38 2.56 1.63
Operating Cash Flow Coverage Ratio
 2.09 4.34 2.92 2.68 81.74
Operating Cash Flow to Sales Ratio
 0.09 0.19 0.16 0.18 0.10
Free Cash Flow Yield
1.04%2.65%2.07%2.03%0.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 37.38 27.20 36.64 38.68 26.74
Price-to-Sales (P/S) Ratio
 5.97 4.35 4.56 5.27 5.76
Price-to-Book (P/B) Ratio
 3.71 2.70 2.80 3.43 2.62
Price-to-Free Cash Flow (P/FCF) Ratio
 96.18 37.74 48.27 49.24 148.28
Price-to-Operating Cash Flow Ratio
 64.72 22.70 27.98 29.98 57.38
Price-to-Earnings Growth (PEG) Ratio
 0.79 0.58 -3.82 -33.98 -0.75
Price-to-Fair Value
 3.71 2.70 2.80 3.43 2.62
Enterprise Value Multiple
 20.29 15.26 18.96 23.05 18.41
Enterprise Value
 353.29B 248.70B 233.52B 298.95B 189.80B
EV to EBITDA
 20.29 15.26 18.96 23.05 18.41
EV to Sales
 5.49 3.87 4.16 5.28 5.24
EV to Free Cash Flow
 88.47 33.58 44.04 49.26 134.76
EV to Operating Cash Flow
 59.55 20.20 25.53 29.99 52.15
Tangible Book Value Per Share
 604.37 604.22 533.96 508.04 482.60
Shareholders’ Equity Per Share
 628.81 628.65 555.44 529.56 483.30
Tax and Other Ratios
Effective Tax Rate
 0.30 0.30 0.34 0.32 0.26
Revenue Per Share
 390.39 390.29 340.92 343.86 220.11
Net Income Per Share
 62.37 62.35 42.40 46.89 47.43
Tax Burden
 0.70 0.70 0.66 0.68 0.74
Interest Burden
 1.10 1.21 1.22 1.17 1.19
Research & Development to Revenue
 0.03 0.03 0.00 0.00 0.06
SG&A to Revenue
 0.08 0.08 0.25 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.00 0.00
Income Quality
 0.59 1.20 1.31 1.29 0.35
Currency in INR